Evidence map›Paper›PMID 34880217›Full record

ArticleNature communications2021

GPR180 is a component of TGFβ signalling that promotes thermogenic adipocyte function and mediates the metabolic effects of the adipocyte-secreted factor CTHRC1.

Lucia Balazova, Miroslav Balaz, Carla Horvath, Áron Horváth, Caroline Moser, Zuzana Kovanicova, Adhideb Ghosh, Umesh Ghoshdastider, Vissarion Efthymiou, Elke Kiehlmann and 14 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 6 countries.

Lucia BalazovaInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Miroslav BalazInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Carla HorvathInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Áron HorváthBiomechanics Laboratory, University Hospital Balgrist, University of Zurich, 8008, Zurich, Switzerland.
Caroline MoserInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Zuzana KovanicovaInstitute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.ORCID http://orcid.org/0000-0002-5449-737X
Adhideb GhoshInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.ORCID http://orcid.org/0000-0002-5160-4571
Umesh GhoshdastiderInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Vissarion EfthymiouInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Elke KiehlmannInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Wenfei SunInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.ORCID http://orcid.org/0000-0001-5762-6010
Hua DongInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.ORCID http://orcid.org/0000-0002-8235-726X
Lianggong DingInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland.
Ez-Zoubir AmriUniversité Côte d'Azur, French National Centre for Scientific Research, Inserm, iBV, 06107, Nice, France.
Pirjo NuutilaTurku PET Centre, University of Turku, 20520, Turku, Finland.ORCID http://orcid.org/0000-0001-9597-338X
Kirsi A VirtanenTurku PET Centre, University of Turku, 20520, Turku, Finland.
Tarja NiemiDepartment of Surgery, Turku University Hospital, 20520, Turku, Finland.
Barbara UkropcovaInstitute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.
Jozef UkropecInstitute of Experimental Endocrinology, Biomedical Research Center at the Slovak Academy of Sciences, 84505, Bratislava, Slovakia.
Pawel PelczarCenter for Transgenic Models, University of Basel, 3350, Basel, Switzerland.
Thorsten LamlaDrug Discovery Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397, Biberach an der Riss, Germany.
Bradford HamiltonCardiometabolic Diseases Research Department, Boehringer Ingelheim Pharma GmbH and Co. KG, 88397, Biberach an der Riss, Germany.
Heike NeubauerCardiometabolic Diseases Research Department, Boehringer Ingelheim Pharma GmbH and Co. KG, 88397, Biberach an der Riss, Germany.ORCID http://orcid.org/0000-0001-8470-968X
Christian WolfrumInstitute of Food, Nutrition and Health, ETH Zürich, 8603, Schwerzenbach, Switzerland. christian-wolfrum@ethz.ch.ORCID http://orcid.org/0000-0002-3862-6805
ETH Zurich · CHSlovak Academy of Sciences · SKBoehringer Ingelheim (Germany) · DEUniversity of Turku · FIUniversity of Zurich · CHInserm · FRTurku University Hospital · FIUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation of thermogenic brown and beige adipocytes is considered as a strategy to improve metabolic control. Here, we identify GPR180 as a receptor regulating brown and beige adipocyte function and whole-body glucose homeostasis, whose expression in humans is associated with improved metabolic control. We demonstrate that GPR180 is not a GPCR but a component of the TGFβ signalling pathway and regulates the activity of the TGFβ receptor complex through SMAD3 phosphorylation. In addition, using genetic and pharmacological tools, we provide evidence that GPR180 is required to manifest Collagen triple helix repeat containing 1 (CTHRC1) action to regulate brown and beige adipocyte activity and glucose homeostasis. In this work, we show that CTHRC1/GPR180 signalling integrates into the TGFβ signalling as an alternative axis to fine-tune and achieve low-grade activation of the pathway to prevent pathophysiological response while contributing to control of glucose and energy metabolism.

Indexed as

Signal TransductionAdipocytes, BeigeAdipocytes, BrownAnimalsEnergy MetabolismExtracellular Matrix ProteinsGlucoseHomeostasisHumansMaleMetabolic DiseasesMetabolic SyndromeMiceMice, Inbred C57BLMice, KnockoutReceptors, G-Protein-CoupledCTHRC1 protein, humanExtracellular Matrix ProteinsGlucoseGPR180 protein, humanReceptors, G-Protein-CoupledTransforming Growth Factor beta

Identifiers

PMID34880217
PMCPMC8655035
OpenAlexW4200102911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.